← All Mainz Biomed NV filings

Mainz Biomed NV Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

MYNZ
Mainz Biomed NV
SCHEDULE: Quantum Cyber N.V. Ownership Update Filed
BP United Inc. and Alexander Gurevich report a combined 9.8% stake in Quantum Cyber N.V. following a joint filing.
MYNZ
Mainz Biomed NV
SCHEDULE: Donahue Boosts Mainz Biomed Stake to 10.7%
Kevin Michael Donahue has reported increasing his beneficial ownership in Mainz Biomed N.V. to 10.7% of common stock.
MYNZ
Mainz Biomed NV
SCHEDULE: Insider Boosts Stake in Mainz Biomed to 10.7%
Kevin Michael Donahue has reported a significant beneficial ownership of 10.7% in Mainz Biomed N.V. common stock.
MYNZ
Mainz Biomed NV
SCHEDULE: Armistice Capital Discloses 9.99% Stake in Mainz Biomed
Armistice Capital and Steven Boyd have disclosed a 9.99% beneficial ownership stake in Mainz Biomed N.V., holding 723,092 ordinary shares.
MYNZ
Mainz Biomed NV
SCHEDULE 13G/A: Armistice Capital and Steven Boyd Disclose 9.99% Passive Stake in MAINZ BIOMED N.V.
Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, revealing a shared beneficial ownership of 9.99% of MAINZ BIOMED N.V.'s Ordinary Shares.
MYNZ
Mainz Biomed NV
SCHEDULE 13G: Armistice Capital and Steven Boyd Disclose 9.99% Stake in MAINZ BIOMED N.V.
Investment firm Armistice Capital, LLC and its managing member Steven Boyd have disclosed a significant passive ownership stake of 9.99% in MAINZ BIOMED N.V. as of December 31, 2024.